首页> 外国专利> u03bau03c1u03c5u03c3u03c4u03b1u03bbu03bbu03b9u03bau03b5u03c2u5f62u5f0fu7684Nuff08u03c4u03c1u03b9u03c4u03bfu03c4u03b1u03b3u03b5u03c2-u03b2u03bfu03c5u03c4u03bfu03beu03c5u03bau03b1u03c1u03b2u03bfu03bdu03c5u03bbuff09-3-u7532u57fa-L-u03b2u03b1u03bbu03c5u03bb-uff087-u6c2f-4-u57fa- 1 -u03b9u03c3u03bfu03bau03b9u03bdu03bfu03bbu03b9u03bdu03c5u03bbuff09u6c27u57fauff09-N-uff08uff081Ruff0c2Suff09-uff081 -u03bau03c5u03bau03bbu03bfu03c0u03c1u03bfu03c0u03c5u03bbu03c3u03bfu03c5u03bbu03c6u03bfu03bdu03c5u03bbuff09u03b2u03b9u03bdu03c5u03bbu03bau03c5u03bau03bbu03bfu03c0u03c1u03bfu03c0u03bau03b1u03c1u03b2u03b1u03bcu03bfu03abu03bbuff09- 2 - I L

u03bau03c1u03c5u03c3u03c4u03b1u03bbu03bbu03b9u03bau03b5u03c2u5f62u5f0fu7684Nuff08u03c4u03c1u03b9u03c4u03bfu03c4u03b1u03b3u03b5u03c2-u03b2u03bfu03c5u03c4u03bfu03beu03c5u03bau03b1u03c1u03b2u03bfu03bdu03c5u03bbuff09-3-u7532u57fa-L-u03b2u03b1u03bbu03c5u03bb-uff087-u6c2f-4-u57fa- 1 -u03b9u03c3u03bfu03bau03b9u03bdu03bfu03bbu03b9u03bdu03c5u03bbuff09u6c27u57fauff09-N-uff08uff081Ruff0c2Suff09-uff081 -u03bau03c5u03bau03bbu03bfu03c0u03c1u03bfu03c0u03c5u03bbu03c3u03bfu03c5u03bbu03c6u03bfu03bdu03c5u03bbuff09u03b2u03b9u03bdu03c5u03bbu03bau03c5u03bau03bbu03bfu03c0u03c1u03bfu03c0u03bau03b1u03c1u03b2u03b1u03bcu03bfu03abu03bbuff09- 2 - I L

机译:u03ba u03c1 u03c5 u03c3 u03c4 u03b1 u03bb u03bb u03b9 u03ba u03b5 u03c2 u5f62 u5f0f u7684N uff08 u03c4 u03c1 u03b9 u03b4 u03b4 u03b4 u03c2- u03b2 u03bf u03c5 u03c4 u03bf u03be u03c5 u03baf u03b1 u03c1 u03b2 u03bf u03bd u03c5 u03bb2 u03bf u09b3 u7532 u57fa-L- u03bb u03c5 u03bb- uff087- u6c2f-4- u57fa- 1- u03b9 u03c3 u03bf u03ba u03b9 u03bd u03bf u03bb u03b9 u03bd u03c5 u03bb uff09 u6c27 uff09-N- uff08 uff081R uff0c2S uff09- uff081- u03ba u03c5 u03c1 u03bf u03c0 u03c5 u03bb u03cf u03bf u03c5 u03c5 u03bb u03bd u03c5 u03bb uff09 u03b2 u03b9 u03bd u03c5 u03bb u03ba u03c5 u03c1 u03bf u03cf u03c0 u03c1 u03bf u03c0 u03bauuubbb u03b1 u03b1 u03ab u03bb uff09- 2-IL

摘要

The present disclosure relates to the general form of crystallization N - (9595_ lambda oxy) - N - ((1R, 2S) - (1 - (ESR) Lambda___lambda__) kappa alpha__lambda) - 2-L-pi_lambda____lambda.Current enlightenment also covers pharmaceutical compositions, which include one or more crystalline forms as well as Mu epsilon theta_delta. The crystalline form of hepatitis C virus (HCV) and crystalline form they used in the lawsuit took this approach.
机译:本公开内容涉及结晶的一般形式N-(9595 _ lambda oxy)-N-(((1R,2S)-(1-(ESR)) Lambda___lambda__)kappa alpha__lambda)-2-L-pi_lambda ____ lambda。目前的启示还涉及药物组合物,包括一种或多种结晶形式以及Muepsilon theta_delta。丙型肝炎病毒(HCV)的结晶形式及其在诉讼中使用的结晶形式采用了这种方法。

著录项

获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号